Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Endogenous Metabolite
    (1)
  • Glucocorticoid Receptor
    (1)
  • Others
    (23)
Filter
Search Result
Results for "

mhc class ii

" in TargetMol Product Catalog
  • Recombinant Protein
    25
    TargetMol | Activity
  • Inhibitor Products
    13
    TargetMol | inventory
  • Peptides Products
    6
    TargetMol | natural
  • Inhibitory Antibodies
    2
    TargetMol | composition
  • Natural Products
    1
    TargetMol | Activity
MHC class II antigen (45-57) [Homo sapiens]
TP2270
MHC class II antigen (45-57) [Homo sapiens] is a peptide with the sequence H2N-Asp-Leu-Asp-Lys-Lys-Glu-Thr-Val-Trp-His-Leu-Glu- Glu-OH, MW= 1868.07. MHC (major histocompatibility complex) class II molecules are found only on antigen-presenting cells and l
  • $50
Backorder
Size
QTY
CFP10 (71–85)
T82743646997-09-3
CFP10 (71–85) is an immunologically active peptide that induces IFN-γ production and cytotoxic T lymphocyte (CTL) activity in CD4+ and CD8+ T cells from individuals with diverse MHC class II and I expression profiles.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
InsB 9-23
TP1126
InsB (9-23) is an insulin B-chain peptide that binds to a class II histocompatibility complex (MHC) allele called I-Ag7.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Influenza NP (311-325)
T820711225029-27-5
Influenza NP (311-325) is a biologically active peptide composed of amino acids 311 to 325 derived from the influenza virus nucleoprotein (NP). As a bona fide MHC class II-restricted epitope, it is instrumental for studying host immune responses during viral infection. It notably induces robust gamma interferon (IFN-gamma) production in intracellular cytokine assays while not stimulating CD8 T-cells in mice. Additionally, the presence of Glutamine (Q) or Glutamic acid (E) at the N-terminus can lead to the spontaneous formation of Pyroglutamyl (pGlu) peptides, which may enhance peptide stability against gastrointestinal proteases through the hydrophobic γ-lactam ring of pGlu. Consequently, these peptides are considered a normal variant and factored into the peptide purity measurements in HPLC analysis.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
NY-ESO-1 (87-111)
T40590508230-31-7
NY-ESO-1 (87-111) is a pan-MHC class II-restricted peptide that interacts with various HLA-DR and HLA-DP4 molecules, inducing activation of CD4+ T cells with Th1-type and Th-2/Th0-type responses, when presented in conjunction with HLA-DR and HLA-DP4 molecules.
  • Inquiry Price
Size
QTY
GAD65 (206-220)
T40115245124-26-9
GAD65 (206-220) is a synthetic peptide derived from glutamic acid decarboxylase (GAD) 65, specifically corresponding to residues 180-188. It is known that GAD65 interacts with I-Ag7 MHC class II molecules and is a significant pancreatic antigen that self-reactive T cells target in type I diabetes mellitus.
  • Inquiry Price
Size
QTY